Aktive Positionen von Olivier Bataille
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
MY01, Inc.
 MY01, Inc. Medical SpecialtiesHealth Technology MY01, Inc. is a Canadian healthcare technology company that aims to improve patient outcomes by providing objective data to aid in the diagnosis of compartment syndrome. MY01 is based in an undisclosed location since 2015 and leverages its expertise in microsensing technology to provide innovative diagnostic solutions. The company believes that adding actionable, quantitative data at the bedside can augment clinical assessments to provide more effective care. The company was founded in 2015 by Charles Allan, George Xereas, and Edward Harvey, with Charles Allan serving as the CEO since then. | Geschäftsführer | 01.05.2019 | - |
Karriereverlauf von Olivier Bataille
Ehemalige bekannte Positionen von Olivier Bataille
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
CryoCath Technologies, Inc.
 CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Geschäftsführer | - | - |
Statistik
International
| Kanada | 3 |
Operativ
| Chief Operating Officer | 2 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
CryoCath Technologies, Inc.
CryoCath Technologies, Inc. Medical SpecialtiesHealth Technology CryoCath Technologies, Inc. manufactures medical equipment. The company was founded by Normand Balthazard and Andre L. Lamotte in 1994 and is headquartered in Montreal, QC. | Health Technology |
MY01, Inc.
MY01, Inc. Medical SpecialtiesHealth Technology MY01, Inc. is a Canadian healthcare technology company that aims to improve patient outcomes by providing objective data to aid in the diagnosis of compartment syndrome. MY01 is based in an undisclosed location since 2015 and leverages its expertise in microsensing technology to provide innovative diagnostic solutions. The company believes that adding actionable, quantitative data at the bedside can augment clinical assessments to provide more effective care. The company was founded in 2015 by Charles Allan, George Xereas, and Edward Harvey, with Charles Allan serving as the CEO since then. | Health Technology |
- Börse
- Insiders
- Olivier Bataille
- Erfahrung
